{"id":"W3164781697","doi":"10.1136/annrheumdis-2021-eular.2644","title":"AB0558 CLINICAL EFFECTIVENESS AND SAFETY OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY IN PSORIATIC ARTHRITIS PATIENTS OVER 24 MONTHS – RESULTS OF THE COMPLETE-PsA CANADIAN OBSERVATIONAL STUDY","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier de l'Université Laval; ABB (Canada); South Bruce Grey Health Centre; University of British Columbia; Memorial University of Newfoundland","funders":"Celgene; Sanofi; Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Adalimumab; Psoriatic arthritis; Internal medicine; Ustekinumab; Golimumab; Rheumatology; Psoriasis; Observational study; Regimen; Clinical endpoint; Tocilizumab; Odds ratio; Physical therapy; Clinical trial; Arthritis; Disease; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003415206,0.000810954,0.002129497,0.0008481406,0.001103359,0.001311663,0.001329906,0.001061162,0.001446704],"category_scores_gemma":[0.004821449,0.0005920711,0.002603682,0.002548697,0.0006871622,0.0007178413,0.0005989898,0.001697391,0.0003638302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005608452,"about_ca_system_score_gemma":0.006739449,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3451084,"about_ca_topic_score_gemma":0.4015992,"domain_scores_codex":[0.997029,0.000721043,0.0002364983,0.0004603183,0.001119259,0.0004338585],"domain_scores_gemma":[0.995073,0.0007432916,0.001711731,0.0003311644,0.001114474,0.001026304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2034334,0.003108536,0.7451862,0.001172933,0.00954795,0.000208512,0.0004960058,0.000657714,0.002131681,0.0001941886,0.003223545,0.03063929],"study_design_scores_gemma":[0.00634904,0.004198489,0.9852469,0.00008435817,0.001721719,0.00009919103,0.0001605549,0.000275093,0.0001384939,0.00003667657,0.001636915,0.00005264088],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867247,0.006331122,0.00005889507,0.0001689817,0.00005274187,0.000166183,0.004994139,0.000009575814,0.001493638],"genre_scores_gemma":[0.9909503,0.002120196,0.0002159628,0.0002182061,0.00009084871,0.00009868007,0.00553878,0.000006484758,0.0007606215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6548916,"threshold_uncertainty_score":0.6861993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1139391079542353,"score_gpt":0.3692297992159853,"score_spread":0.2552906912617501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}